Pharmacodynamic effects of cangrelor on platelet P2Y12 receptor-mediated signaling in prasugrel-treated patients. [electronic resource]
Producer: 20141212Description: 426-34 p. digitalISSN:- 1876-7605
- Adenosine Monophosphate -- analogs & derivatives
- Aged
- Blood Platelets -- drug effects
- Cell Adhesion Molecules -- blood
- Coronary Artery Disease -- blood
- Drug Administration Schedule
- Female
- Florida
- Humans
- Male
- Microfilament Proteins -- blood
- Middle Aged
- Percutaneous Coronary Intervention
- Phosphoproteins -- blood
- Phosphorylation
- Piperazines -- administration & dosage
- Platelet Aggregation Inhibitors -- administration & dosage
- Platelet Function Tests
- Prasugrel Hydrochloride
- Prospective Studies
- Purinergic P2Y Receptor Antagonists -- administration & dosage
- Receptors, Purinergic P2Y12 -- blood
- Signal Transduction -- drug effects
- Thiophenes -- administration & dosage
- Time Factors
- Vasodilator-Stimulated Phosphoprotein
No physical items for this record
Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.